German multinational pharmaceutical, chemical, and agricultural biotechnology company

Bayer is a publicly traded, multinational company headquartered in Leverkusen, Germany. Founded over 150 years ago, its core competencies presently lie in the life science fields of health care and agriculture.

The company's life science unit has 3 main divisions, pharmaceuticals, consumer health, and crop science. It also has an animal health unit as well as a corporate functions business services unit. In addition, Bayer has a 60% stake in Currenta, a company offering services for the chemical industry including utility supply, waste management, infrastructure, safety, security, analytics, and vocational training.

In terms of sales, Bayer's pharmaceuticals segment is the largest in the company. The focus of this segment is primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology, and ophthalmology. Principal research centers are located in Germany, United States, Finland, and Norway.

The consumer health division focuses on everyday healthcare, where the company has a portfolio of over 170 brands to treat minor illnesses. The products are in areas such as, digestive health, allergies, skin conditions, pain management, nutritional supplements, and common colds.

Bayer's crop sciences division focuses on delivering solutions to farmers in areas such as crop protection, seeds and traits, as well as digital farming. In June 2018, Bayer completed its acquisition of Monsanto for approximately $63 billion. In connection with regulatory approval processes, the company agreed to divest portions of its businesses to BASF.

The company's animal health unit develops and markets products and solutions for the prevention and treatment of diseases in companion and farm animals. In November 2018, Bayer announced its plan to sell the unit, which is estimated to be worth up to €7 billion, along with several other brands. The move is estimated to result in about 12,000 job cuts worldwide.

Bayer's business services unit is an in-house center for business solutions and business support process of the Bayer Group. Its portfolio ranges from development and implementation of IT-based solutions and design, building and execution of end-to-end process operations to in-house management consulting.


June 24, 2020

Bayer says it will pay up to US$10.9 billion to settle litigation over the subsidiary Monsanto's weedkiller Roundup, which has faced thousands of lawsuits over claims it causes cancer.

October 1, 2019

Bayer says it is to spend more than 25 billion euros ($27.22 billion) on research and development at its agriculture unit over the next 10 years.

August 7, 2019

Reuters reported last September initial plans by Bayer to divest its 60% stake in the chemical park operator, part of a string of assets it has put on the block to slash debt since its $63 billion takeover of Monsanto last year.

June 2019

Bayer announces that it is planning to invest $5.6 billion over the next 10 years in research on weed control.

March 25, 2019

Johnson & Johnson and Bayer agree to pay $775 million to settle about 25,000 lawsuits involving the blood thinner Xarelto, which they jointly sell.


Bayer acquires Monsanto for $63 billion.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Bayer Venture round, April 2018
Venture round
April 17, 2018
Temasek Holdings
1 Result
Page 1 of 1
Results per page:
Powered by Golden Research Engine



Amir Morani


Carmen Ionescu


Debra Lopez Quiat


Dr. Hartmut Klusik

Labor Director, Human Resources, Technology, & Sustainability

Heiko Schipper

President, Consumer Health Division

Kemal Malik

Innovation & Head of Latin America

Liam Condon

President, Crop Science Division & Animal Health Business Unit

Mary Kalnas


Stefan Oelrich

Head of Pharmaceuticals Division

Werner Baumann

Chairman & CEO

Wolfgang Nickl

CFO & Head of Asia Pacific and North America

Further reading


Bayer Completes Monsanto Acquisition for $63 Billion


Bayer to cut 12,000 jobs and sell brands


Documentaries, videos and podcasts





Jonathan Shieber
August 11, 2020
With a slew of partnerships with large pharmaceutical companies under its belt and the successful spin out of at least one new company, Atomwise has already proved the value of its machine learning platform for discovering and commercializing potential small molecule therapies for a host of conditions. Now the company has raised $123 million in [...]
Press Trust of India
August 6, 2020
Total income rose to Rs 1,242.7 crore in the first quarter of the fiscal, from Rs 969 crore in the corresponding period of the previous year
Amirah Al Idrus
July 9, 2020
Five years after kicking off a massive phase 3 program, Bayer has good news for its heart failure pill finerenone. The drug beat placebo at staving off progression of kidney disease and lowered the risk of heart attacks and strokes in patients with chronic kidney disease and Type 2 diabetes.
Australian Associated Press
June 25, 2020
the Guardian
Monsanto's Roundup spray. The pesticides giant Bayer has agreed overnight to pay up to US$16bn to settle about 95,000 cases claiming the weedkiller caused cancer. Photograph: Régis Duvignau/Reuters
The Associated Press
June 24, 2020
German pharmaceutical company Bayer says it's paying up to US$10.9 billion to settle a lawsuit over subsidiary Monsanto's weedkiller Roundup, which has faced numerous lawsuits over claims it causes cancer.
Ram Prasad Sahu
June 23, 2020
The sharp rerating of the sector and the company has taken valuations into expensive zone
Reuters Editorial
June 8, 2020
Elanco Animal Health secured EU antitrust clearance on Monday to buy Bayer's veterinary drugs unit after pledging to sell some products to address competition concerns about the $7.6 billion deal.
June 3, 2020
Bayer veteran tasked with driving commercialization of proprietary Acoustic Cluster Therapy(ACT®)-based pipeline at EXACT Therapeutics, formerly known as Phoenix Solutions
June 1, 2020
The newly named WaveForm Diabetes (formerly AgaMatrix Holdings) welcomes new Executive Chairman and CEO, Rick Valencia, to further the company's growth and expansion into global markets
June 1, 2020
Bayer Launches the Second Annual Pulmonary Hypertension Accelerated Bayer (PHAB) Awards to Encourage and Recognize Innovation in Pulmonary Research - read this article along with other careers information, tips and advice on BioSpace
May 29, 2020
The Efficacy of Vitrakvi® (larotrectinib) Further Demonstrated High Response Rates and Duration of Response in an Updated Analysis and New Quality of Life Data to Be Presented at ASCO - read this article along with other careers information, tips and advice on BioSpace
Ludwig Burger
May 25, 2020
Bayer said on Monday it had made progress seeking a settlement over claims its glyphosate-based Roundup weedkiller causes cancer, after Bloomberg reported the company reached a verbal agreement on about 50,000 to 85,000 cases.
Mark Terry
May 18, 2020
Clinical trial updates not related to COVID-19 are on the upswing, partly because some companies are announcing trial information ahead of the upcoming American Society of Clinical Oncology virtual meeting being held at the end of the month. Here's a look.
May 14, 2020
Bayer and ArcherDX Announce Global Collaboration to Develop Next-Generation Sequencing (NGS)-based Companion Diagnostic (CDx) for VITRAKVI® (larotrectinib) - read this article along with other careers information, tips and advice on BioSpace
Reuters Editorial
April 28, 2020
Bayer shareholders on Tuesday voted in favour of ratifying the executive board's business conduct during 2019, following a rebuke a year earlier.
Reuters Editorial
April 27, 2020
German drugs and pesticides company Bayer said the economic downturn due to the coronavirus has prompted it to take a tougher stance in talks to settle claims its glyphosate-based weedkillers cause cancer.
April 17, 2020
Although some rules can be waived in an emergency, the FDA dropped its quality-control standards too far as it scoured the world for scarce supplies of chloroquine drugs.
Reuters Editorial
April 15, 2020
Shareholder advisory groups are divided over whether to endorse the management and directors at German drugs and pesticides company Bayer , according to recommendations submitted by proxy voting firms.
Natasha Singer | NYT
March 15, 2020
Book review of PHARMA: Greed, Lies, and the Poisoning of America
Damian Carrington Environment editor
March 12, 2020
the Guardian
Glyphosate is the world's most widely used weedkiller. In 2015, the World Health Organization's cancer agency, the IARC, declared that it was probably carcinogenic. Photograph: Christian Hartmann/Reuters


Page 1 of 2
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.